Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model.
There are no effective therapeutics that antagonize or reverse the protein-misfolding events underpinning polyglutamine (PolyQ) disorders, including Spinocerebellar Ataxia Type-3 (SCA3). Here, we augment the proteostasis network of Drosophila SCA3 models with Hsp104, a powerful protein disaggregase...
Saved in:
Main Authors: | Mimi Cushman-Nick, Nancy M Bonini, James Shorter |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Genetics |
Online Access: | https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1003781&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial 10.4
Published: (2024-12-01) -
Glutamine missense suppressor transfer RNAs inhibit polyglutamine aggregation
by: Rasangi Tennakoon, et al.
Published: (2025-03-01) -
Population genetics of spinoсerebellar ataxias caused by polyglutamine expansions
by: A. N. Shuvaev, et al.
Published: (2019-07-01) -
Biochemical analysis to study wild-type and polyglutamine-expanded ATXN3 species.
by: Grégoire Quinet, et al.
Published: (2024-01-01) -
Differentiation-Associated MicroRNA Alterations in Mouse Heart-Derived Sca-1+CD31− and Sca-1+CD31+ Cells
by: Qiong Wu, et al.
Published: (2016-01-01)